ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE000MLMNYS0
Stock Name / FundiShares S&P 500 Equal Weight UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerEWSP.AS(USD) CXE
ETF TickerEWSP.LS(GBP) CXE
ETF TickerEWSP.MI(EUR) CXE
ETF TickerEWSP(EUR) ETF Plus

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Equal Weight UCITS ETF USD (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-12-03 (Wednesday)14,403REGN holding increased by 40USD 10,423,019REGN holding decreased by -234327USD 10,423,01940USD -234,327 USD 723.67 USD 742
2025-12-02 (Tuesday)14,363USD 10,657,346REGN holding decreased by -116484USD 10,657,3460USD -116,484 USD 742 USD 750.11
2025-12-01 (Monday)14,363REGN holding increased by 50USD 10,773,830REGN holding decreased by -393029USD 10,773,83050USD -393,029 USD 750.11 USD 780.19
2025-11-28 (Friday)14,313REGN holding increased by 110USD 11,166,859REGN holding increased by 23043USD 11,166,859110USD 23,043 USD 780.19 USD 784.61
2025-11-26 (Wednesday)14,203USD 11,143,816REGN holding decreased by -38490USD 11,143,8160USD -38,490 USD 784.61 USD 787.32
2025-11-25 (Tuesday)14,203USD 11,182,306REGN holding increased by 367432USD 11,182,3060USD 367,432 USD 787.32 USD 761.45
2025-11-24 (Monday)14,203REGN holding increased by 180USD 10,814,874REGN holding increased by 214888USD 10,814,874180USD 214,888 USD 761.45 USD 755.9
2025-11-21 (Friday)14,023REGN holding increased by 20USD 10,599,986REGN holding increased by 279775USD 10,599,98620USD 279,775 USD 755.9 USD 737
2025-11-20 (Thursday)14,003USD 10,320,211REGN holding increased by 479603USD 10,320,2110USD 479,603 USD 737 USD 702.75
2025-11-19 (Wednesday)14,003USD 9,840,608REGN holding decreased by -316328USD 9,840,6080USD -316,328 USD 702.75 USD 725.34
2025-11-18 (Tuesday)14,003USD 10,156,936REGN holding increased by 294483USD 10,156,9360USD 294,483 USD 725.34 USD 704.31
2025-11-17 (Monday)14,003USD 9,862,453REGN holding increased by 151372USD 9,862,4530USD 151,372 USD 704.31 USD 693.5
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE000MLMNYS0

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03BUY40744.225720.140 722.549USD 28,902 651.52
2025-12-01BUY50779.840748.210 751.373USD 37,569 650.74
2025-11-28BUY110 780.190* 650.20
2025-11-24BUY180773.130756.640 758.289USD 136,492 648.59
2025-11-21BUY20 755.900* 648.14
2025-11-11SELL-10676.330651.410 653.902USD -6,539 646.27 Loss of -76 on sale
2025-11-07BUY70 657.530* 646.18
2025-11-05SELL-680646.895628.000 629.890USD -428,325 646.18 Profit of 11,080 on sale
2025-10-29SELL-538652.910659.980 659.273USD -354,689 646.19 Loss of -7,037 on sale
2025-10-24SELL-110577.950582.700 582.225USD -64,045 646.75 Profit of 7,098 on sale
2025-10-23SELL-20575.690584.000 583.169USD -11,663 647.08 Profit of 1,278 on sale
2025-10-22BUY30584.740588.710 588.313USD 17,649 647.37
2025-10-20SELL-230576.770582.650 582.062USD -133,874 648.02 Profit of 15,170 on sale
2025-10-17SELL-120578.050579.040 578.941USD -69,473 648.35 Profit of 8,329 on sale
2025-10-16SELL-50569.170589.080 587.089USD -29,354 648.72 Profit of 3,082 on sale
2025-10-15SELL-125576.420584.870 584.025USD -73,003 649.07 Profit of 8,131 on sale
2025-10-13SELL-187557.730563.770 563.166USD -105,312 649.88 Profit of 16,215 on sale
2025-10-03BUY40600.000618.010 616.209USD 24,648 650.76
2025-10-02SELL-400600.000605.410 604.869USD -241,948 651.01 Profit of 18,455 on sale
2025-10-01SELL-383599.940615.390 613.845USD -235,103 651.26 Profit of 14,329 on sale
2025-09-30SELL-10562.270574.040 572.863USD -5,729 651.70 Profit of 788 on sale
2025-09-29SELL-132560.750564.910 564.494USD -74,513 652.15 Profit of 11,571 on sale
2025-09-26SELL-10563.900564.610 564.539USD -5,645 652.59 Profit of 881 on sale
2025-09-25BUY130555.510579.000 576.651USD 74,965 653.08
2025-09-24SELL-88576.980577.980 577.880USD -50,853 653.47 Profit of 6,651 on sale
2025-09-18BUY20598.710600.000 599.871USD 11,997 653.74
2025-09-10SELL-10555.830560.000 559.583USD -5,596 656.39 Profit of 968 on sale
2025-09-08SELL-10558.440571.200 569.924USD -5,699 657.44 Profit of 875 on sale
2025-08-21BUY20598.160605.180 604.478USD 12,090 657.75
2025-08-19BUY18571.780581.690 580.699USD 10,453 658.57
2025-07-31SELL-411545.460558.130 556.863USD -228,871 659.61 Profit of 42,229 on sale
2025-07-29BUY11558.150559.610 559.464USD 6,154 660.75
2025-07-23SELL-30572.390576.700 576.269USD -17,288 662.32 Profit of 2,582 on sale
2025-07-22SELL-60560.930563.000 562.793USD -33,768 662.89 Profit of 6,006 on sale
2025-07-21SELL-20545.530552.980 552.235USD -11,045 663.55 Profit of 2,226 on sale
2025-07-11SELL-30567.740568.460 568.388USD -17,052 664.10 Profit of 2,871 on sale
2025-07-10SELL-120559.760566.370 565.709USD -67,885 664.69 Profit of 11,878 on sale
2025-07-09SELL-40552.580558.380 557.800USD -22,312 665.34 Profit of 4,302 on sale
2025-07-08SELL-130547.750559.460 558.289USD -72,578 666.02 Profit of 14,005 on sale
2025-07-03SELL-170547.360555.000 554.236USD -94,220 668.17 Profit of 19,368 on sale
2025-07-02SELL-31547.740551.500 551.124USD -17,085 668.88 Profit of 3,650 on sale
2025-06-30BUY446525.000526.080 525.972USD 234,584 669.74
2025-06-27SELL-490521.000531.210 530.189USD -259,793 670.63 Profit of 68,815 on sale
2025-06-25BUY10520.290525.630 525.096USD 5,251 672.44
2025-06-24SELL-370522.270527.450 526.932USD -194,965 673.36 Profit of 54,179 on sale
2025-06-18SELL-42513.580519.170 518.611USD -21,782 675.33 Profit of 6,582 on sale
2025-06-17SELL-77508.860523.010 521.595USD -40,163 676.37 Profit of 11,917 on sale
2025-06-11SELL-21518.600528.370 527.393USD -11,075 680.27 Profit of 3,210 on sale
2025-06-10SELL-49523.530529.990 529.344USD -25,938 681.28 Profit of 7,445 on sale
2025-06-06SELL-14493.220499.880 499.214USD -6,989 683.56 Profit of 2,581 on sale
2025-06-05SELL-119483.070491.770 490.900USD -58,417 684.87 Profit of 23,083 on sale
2025-06-02SELL-567490.810502.560 501.385USD -284,285 688.81 Profit of 106,271 on sale
2025-05-30SELL-126490.280519.780 516.830USD -65,121 690.14 Profit of 21,838 on sale
2025-05-29SELL-14605.390605.730 605.696USD -8,480 690.72 Profit of 1,190 on sale
2025-05-27SELL-14603.260608.170 607.679USD -8,508 691.99 Profit of 1,180 on sale
2025-05-23SELL-21588.340591.640 591.310USD -12,418 693.43 Profit of 2,145 on sale
2025-05-16SELL-105594.320595.190 595.103USD -62,486 696.74 Profit of 10,672 on sale
2025-05-15SELL-21584.990585.260 585.233USD -12,290 697.55 Profit of 2,359 on sale
2025-05-13SELL-7574.160575.050 574.961USD -4,025 699.39 Profit of 871 on sale
2025-05-12SELL-49575.630577.990 577.754USD -28,310 700.30 Profit of 6,005 on sale
2025-05-09SELL-42527.780552.840 550.334USD -23,114 701.59 Profit of 6,353 on sale
2025-05-08SELL-203547.670552.570 552.080USD -112,072 702.75 Profit of 30,586 on sale
2025-05-07SELL-14560.930568.130 567.410USD -7,944 703.82 Profit of 1,910 on sale
2025-05-06BUY8558.520606.870 602.035USD 4,816 704.93
2025-05-01BUY266590.000593.930 593.537USD 157,881 707.40
2025-04-30BUY147598.760600.200 600.056USD 88,208 708.25
2025-04-29SELL-28568.910579.980 578.873USD -16,208 709.36 Profit of 3,654 on sale
2025-04-28SELL-35610.860614.830 614.433USD -21,505 710.15 Profit of 3,350 on sale
2025-04-25BUY14602.640602.790 602.775USD 8,439 711.01
2025-04-24SELL-7599.760601.280 601.128USD -4,208 711.92 Profit of 776 on sale
2025-04-22SELL-938585.490587.100 586.939USD -550,549 713.99 Profit of 119,173 on sale
2025-04-17SELL-427563.160564.210 564.105USD -240,873 717.84 Profit of 65,644 on sale
2025-04-16BUY14549.280561.830 560.575USD 7,848 719.28
2025-04-15BUY14557.910575.200 573.471USD 8,029 720.67
2025-04-10SELL-441546.390571.990 569.430USD -251,119 725.01 Profit of 68,610 on sale
2025-04-09BUY35576.720580.730 580.329USD 20,312 726.33
2025-04-08BUY7556.810586.030 583.108USD 4,082 727.86
2025-04-07BUY126572.780591.540 589.664USD 74,298 729.27
2025-04-04BUY77573.450612.990 609.036USD 46,896 730.70
2025-04-02BUY49625.600628.000 627.760USD 30,760 731.67
2025-04-01BUY553617.000641.240 638.816USD 353,265 732.74
2025-03-31BUY21634.230640.720 640.071USD 13,441 733.67
2025-03-25BUY7634.140662.570 659.727USD 4,618 737.47
2025-03-21BUY578658.480661.000 660.748USD 381,912 739.02
2025-03-20BUY14662.620674.830 673.609USD 9,431 739.80
2025-03-18BUY35664.960678.270 676.939USD 23,693 741.26
2025-03-17BUY7678.420679.830 679.689USD 4,758 741.92
2025-03-13SELL-420680.610698.950 697.116USD -292,789 743.37 Profit of 19,426 on sale
2025-03-12BUY84689.500712.460 710.164USD 59,654 743.95
2025-03-11BUY84718.160747.700 744.746USD 62,559 744.23
2025-03-07BUY28707.510729.750 727.526USD 20,371 744.63
2025-03-06BUY98698.440701.000 700.744USD 68,673 745.15
2025-03-05BUY532687.150692.790 692.226USD 368,264 745.81
2025-03-04BUY28675.490697.460 695.263USD 19,467 746.62
2025-03-03BUY35684.870704.640 702.663USD 24,593 747.33
2025-02-28BUY70698.740708.580 707.596USD 49,532 747.91
2025-02-27BUY63702.780721.000 719.178USD 45,308 748.44
2025-02-26SELL-35706.940721.410 719.963USD -25,199 748.94 Profit of 1,014 on sale
2025-02-25SELL-7723.470739.000 737.447USD -5,162 749.25 Profit of 83 on sale
2025-02-24BUY7713.250725.000 723.825USD 5,067 749.70
2025-02-20SELL-91696.020703.140 702.428USD -63,921 751.00 Profit of 4,420 on sale
2025-02-19BUY28685.660688.670 688.369USD 19,274 751.84
2025-02-18BUY28680.000689.950 688.955USD 19,291 752.77
2025-02-13BUY798674.270677.690 677.348USD 540,524 755.97
2025-02-12BUY238663.860670.980 670.268USD 159,524 757.24
2025-02-11BUY196665.460680.790 679.257USD 133,134 758.51
2025-02-07BUY21710.000731.420 729.278USD 15,315 760.18
2025-02-06BUY280722.070734.270 733.050USD 205,254 760.73
2025-02-05BUY140716.720729.250 727.997USD 101,920 761.38
2025-02-04BUY105697.050709.980 708.687USD 74,412 762.34
2025-02-03SELL-609666.850673.650 672.970USD -409,839 763.78 Profit of 55,305 on sale
2025-01-31BUY56672.980688.000 686.498USD 38,444 765.18
2025-01-30BUY7683.080689.620 688.966USD 4,823 766.46
2025-01-29BUY119687.270697.570 696.540USD 82,888 767.72
2025-01-28BUY42686.330690.300 689.903USD 28,976 769.03
2025-01-27BUY42684.710698.450 697.076USD 29,277 770.41
2025-01-24BUY42675.790693.840 692.035USD 29,065 771.99
2025-01-23BUY119694.640696.190 696.035USD 82,828 773.30
2025-01-22BUY70680.030699.880 697.895USD 48,853 774.91
2025-01-21BUY413687.800692.930 692.417USD 285,968 776.44
2025-01-17BUY84681.580707.480 704.890USD 59,211 779.89
2025-01-15BUY42703.430712.600 711.683USD 29,891 782.97
2025-01-13BUY119716.900717.370 717.323USD 85,361 786.07
2025-01-10BUY91696.880724.730 721.945USD 65,697 787.85
2024-12-31BUY21712.330713.000 712.933USD 14,972 793.43
2024-12-30BUY28702.590708.970 708.332USD 19,833 795.45
2024-12-27BUY133712.400718.990 718.331USD 95,538 797.34
2024-12-23BUY42715.130718.190 717.884USD 30,151 803.33
2024-12-20BUY4,328701.850717.610 716.034USD 3,098,995 805.87
2024-12-19BUY48708.250714.050 713.470USD 34,247 808.37
2024-12-17BUY36740.010744.800 744.321USD 26,796 812.75
2024-12-16BUY12724.870739.390 737.938USD 8,855 815.19
2024-12-13BUY20731.300740.170 739.283USD 14,786 817.59
2024-12-11BUY12773.000781.320 780.488USD 9,366 818.90
2024-12-10BUY8778.500791.490 790.191USD 6,322 820.13
2024-12-09BUY8788.000800.990 799.691USD 6,398 821.13
2024-12-05SELL-24767.900768.020 768.008USD -18,432 824.34 Profit of 1,352 on sale
2024-12-04BUY4754.260756.130 755.943USD 3,024 826.76
2024-12-02BUY16762.340763.890 763.735USD 12,220 832.00
2024-11-29BUY72750.220754.510 754.081USD 54,294 835.15
2024-11-27BUY16754.870762.160 761.431USD 12,183 841.84
2024-11-26BUY40753.030754.180 754.065USD 30,163 845.70
2024-11-25BUY496749.510757.860 757.025USD 375,484 850.07
2024-11-22BUY12738.000751.400 750.060USD 9,001 855.41
2024-11-21BUY12744.500757.560 756.254USD 9,075 860.96
2024-11-20BUY52743.350750.690 749.956USD 38,998 867.15
2024-11-19SELL-52744.600758.600 757.200USD -39,374 873.95 Profit of 6,071 on sale
2024-11-18BUY240762.000762.700 762.630USD 183,031 880.54
2024-11-12BUY48821.000831.000 830.000USD 39,840 884.26
2024-11-11BUY12825.680834.420 833.546USD 10,003 888.17
2024-11-08BUY48828.420830.730 830.499USD 39,864 892.43
2024-11-07BUY80824.480832.530 831.725USD 66,538 897.66
2024-11-06BUY36816.650844.510 841.724USD 30,302 904.41
2024-11-05BUY8829.430836.630 835.910USD 6,687 911.23
2024-11-04BUY40828.840852.010 849.693USD 33,988 919.47
2024-11-01BUY20843.600862.000 860.160USD 17,203 927.90
2024-10-31SELL-184838.200883.150 878.655USD -161,673 939.11 Profit of 11,124 on sale
2024-10-30BUY12922.790935.860 934.553USD 11,215 941.44
2024-10-29BUY76927.330932.380 931.875USD 70,823 943.79
2024-10-25BUY16933.020943.830 942.749USD 15,084 950.28
2024-10-24BUY12928.900952.020 949.708USD 11,396 957.41
2024-10-22BUY24962.340972.750 971.709USD 23,321 968.50
2024-10-21BUY20968.500991.240 988.966USD 19,779 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy